BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38029383)

  • 1. Functional relevance of circRNA aberrant expression in pediatric acute leukemia with KMT2A::AFF1 fusion.
    Tretti Parenzan C; Molin AD; Longo G; Gaffo E; Buratin A; Cani A; Boldrin E; Serafin V; Guglielmelli P; Vannucchi AM; Cazzaniga G; Biondi A; Locatelli F; Meyer LH; Buldini B; Te Kronnie G; Bresolin S; Bortoluzzi S
    Blood Adv; 2024 Mar; 8(5):1305-1319. PubMed ID: 38029383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of fusion circular RNAs in leukemia with KMT2A::AFF1 rearrangements by the new software CircFusion.
    Dal Molin A; Tretti Parenzan C; Gaffo E; Borin C; Boldrin E; Meyer LH; Te Kronnie G; Bresolin S; Bortoluzzi S
    Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36585787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A KMT2A-AFF1 gene regulatory network highlights the role of core transcription factors and reveals the regulatory logic of key downstream target genes.
    Harman JR; Thorne R; Jamilly M; Tapia M; Crump NT; Rice S; Beveridge R; Morrissey E; de Bruijn MFTR; Roberts I; Roy A; Fulga TA; Milne TA
    Genome Res; 2021 Jul; 31(7):1159-1173. PubMed ID: 34088716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged acute lymphoblastic leukemia.
    Schneider P; Crump NT; Arentsen-Peters STCJM; Smith AL; Hagelaar R; Adriaanse FRS; Bos RS; de Jong A; Nierkens S; Koopmans B; Milne TA; Pieters R; Stam RW
    Exp Hematol Oncol; 2023 Sep; 12(1):81. PubMed ID: 37740239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. circRNA circAF4 functions as an oncogene to regulate MLL-AF4 fusion protein expression and inhibit MLL leukemia progression.
    Huang W; Fang K; Chen TQ; Zeng ZC; Sun YM; Han C; Sun LY; Chen ZH; Yang QQ; Pan Q; Luo XQ; Wang WT; Chen YQ
    J Hematol Oncol; 2019 Oct; 12(1):103. PubMed ID: 31623653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a human induced pluripotent stem cell line harboring the infant leukemia-associated fusion gene, KMT2A-AFF1 (IMSUTi002-A-2).
    Takahashi M
    Stem Cell Res; 2023 Sep; 71():103185. PubMed ID: 37639801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis.
    Agraz-Doblas A; Bueno C; Bashford-Rogers R; Roy A; Schneider P; Bardini M; Ballerini P; Cazzaniga G; Moreno T; Revilla C; Gut M; Valsecchi MG; Roberts I; Pieters R; De Lorenzo P; Varela I; Menendez P; Stam RW
    Haematologica; 2019 Jun; 104(6):1176-1188. PubMed ID: 30679323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amlexanox Downregulates S100A6 to Sensitize
    Tamai H; Yamaguchi H; Miyake K; Takatori M; Kitano T; Yamanaka S; Yui S; Fukunaga K; Nakayama K; Inokuchi K
    Cancer Res; 2017 Aug; 77(16):4426-4433. PubMed ID: 28646023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale circular RNA deregulation in T-ALL: unlocking unique ectopic expression of molecular subtypes.
    Buratin A; Paganin M; Gaffo E; Dal Molin A; Roels J; Germano G; Siddi MT; Serafin V; De Decker M; Gachet S; Durinck K; Speleman F; Taghon T; Te Kronnie G; Van Vlierberghe P; Bortoluzzi S
    Blood Adv; 2020 Dec; 4(23):5902-5914. PubMed ID: 33259601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGA2 as a potential molecular target in KMT2A-AFF1-positive infant acute lymphoblastic leukaemia.
    Wu Z; Eguchi-Ishimae M; Yagi C; Iwabuki H; Gao W; Tauchi H; Inukai T; Sugita K; Ishii E; Eguchi M
    Br J Haematol; 2015 Dec; 171(5):818-29. PubMed ID: 26403224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy- (Blinatumomab-) Related Lineage Switch of
    He RR; Nayer Z; Hogan M; Cuevo RS; Woodward K; Heyer D; Curtis CA; Peterson JF
    Case Rep Hematol; 2019; 2019():7394619. PubMed ID: 31885955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haploidentical peripheral blood stem cell transplantation without irradiation or busulfan after reduced-intensity conditioning for KMT2A(MLL)-rearranged infant B-cell precursor acute lymphoblastic leukemia: Report of two cases.
    Yoshimi A; Kato K; Hosaka S; Suzuki R; Fukushima H; Nakao T; Kobayashi C; Fukushima T; Koike K; Sumazaki R; Tsuchida M
    Pediatr Transplant; 2017 Jun; 21(4):. PubMed ID: 28332262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and Epigenetic Characterization of a Discordant
    Russo A; Viberti C; Mareschi K; Casalone E; Guarrera S; Birolo G; Cazzaniga G; Corral L; Trentin L; Basso G; Fagioli F; Matullo G
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA differential expression in blood cell populations and exploration of circRNA deregulation in pediatric acute lymphoblastic leukemia.
    Gaffo E; Boldrin E; Dal Molin A; Bresolin S; Bonizzato A; Trentin L; Frasson C; Debatin KM; Meyer LH; Te Kronnie G; Bortoluzzi S
    Sci Rep; 2019 Oct; 9(1):14670. PubMed ID: 31605010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CircRNAs Are Here to Stay: A Perspective on the
    Dal Molin A; Bresolin S; Gaffo E; Tretti C; Boldrin E; Meyer LH; Guglielmelli P; Vannucchi AM; Te Kronnie G; Bortoluzzi S
    Front Genet; 2019; 10():88. PubMed ID: 30815012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Leukemogenic pathway of infant leukemia with MLL fusion].
    Eguchi M
    Rinsho Ketsueki; 2021; 62(7):809-819. PubMed ID: 34349066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of KMT2A fusion partner genes in 13 cases of pediatric leukemia with complex or cryptic karyotypes.
    Ney Garcia DR; de Souza MT; de Figueiredo AF; Othman MAK; Rittscher K; Abdelhay E; Capela de Matos RR; Meyer C; Marschalek R; Land MGP; Liehr T; Ribeiro RC; Silva MLM
    Hematol Oncol; 2017 Dec; 35(4):760-768. PubMed ID: 27282883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates in
    Górecki M; Kozioł I; Kopystecka A; Budzyńska J; Zawitkowska J; Lejman M
    Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial efficacy of entospletinib and chemotherapy in patient-derived xenograft models of infant acute lymphoblastic leukemia.
    Loftus JP; Yahiaoui A; Brown PA; Niswander LM; Bagashev A; Wang M; Schauf A; Tannheimer S; Tasian SK
    Haematologica; 2021 Apr; 106(4):1067-1078. PubMed ID: 32414848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia.
    Urtishak KA; Wang LS; Culjkovic-Kraljacic B; Davenport JW; Porazzi P; Vincent TL; Teachey DT; Tasian SK; Moore JS; Seif AE; Jin S; Barrett JS; Robinson BW; Chen IL; Harvey RC; Carroll MP; Carroll AJ; Heerema NA; Devidas M; Dreyer ZE; Hilden JM; Hunger SP; Willman CL; Borden KLB; Felix CA
    Oncogene; 2019 Mar; 38(13):2241-2262. PubMed ID: 30478448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.